GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is rapidly emerging as a major focus in healthcare studies, largely due to its notable impact on treating diseases such as adult-onset diabetes and obesity. Recent studies have demonstrated that in addition to glucose control, GLP-1 medications offer potential for cardiovascular health … Read More